A detailed history of Spire Wealth Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Spire Wealth Management holds 16,277 shares of NVO stock, worth $1.97 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
16,277
Previous 14,399 13.04%
Holding current value
$1.97 Million
Previous $1.85 Million 25.7%
% of portfolio
0.08%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$122.71 - $146.91 $230,449 - $275,896
1,878 Added 13.04%
16,277 $2.32 Million
Q1 2024

Apr 24, 2024

BUY
$102.11 - $135.92 $519,025 - $690,881
5,083 Added 54.56%
14,399 $1.85 Million
Q4 2023

Feb 06, 2024

BUY
$87.78 - $105.45 $281,686 - $338,389
3,209 Added 52.55%
9,316 $963,000
Q3 2023

Nov 08, 2023

BUY
$90.94 - $199.54 $278,276 - $610,592
3,060 Added 100.43%
6,107 $555,000
Q2 2023

Aug 09, 2023

SELL
$155.98 - $172.65 $37,279 - $41,263
-239 Reduced 7.27%
3,047 $493,000
Q1 2023

May 09, 2023

BUY
$132.34 - $159.14 $188,187 - $226,297
1,422 Added 76.29%
3,286 $522,000
Q4 2022

Feb 03, 2023

BUY
$102.55 - $135.33 $15,690 - $20,705
153 Added 8.94%
1,864 $252,000
Q3 2022

Nov 07, 2022

SELL
$95.28 - $116.93 $179,412 - $220,179
-1,883 Reduced 52.39%
1,711 $170,000
Q2 2022

Jul 22, 2022

SELL
$103.24 - $121.81 $214,223 - $252,755
-2,075 Reduced 36.6%
3,594 $400,000
Q1 2022

Apr 18, 2022

SELL
$93.1 - $112.54 $159,852 - $193,231
-1,717 Reduced 23.25%
5,669 $630,000
Q4 2021

Jan 14, 2022

BUY
$95.88 - $117.08 $39,214 - $47,885
409 Added 5.86%
7,386 $827,000
Q3 2021

Oct 22, 2021

SELL
$84.42 - $106.62 $73,614 - $92,972
-872 Reduced 11.11%
6,977 $670,000
Q2 2021

Jul 26, 2021

SELL
$67.66 - $84.76 $472,740 - $592,218
-6,987 Reduced 47.09%
7,849 $658,000
Q1 2021

May 21, 2021

BUY
$67.06 - $75.82 $994,902 - $1.12 Million
14,836 New
14,836 $1 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $273B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.